Works matching IS 11738804 AND DT 2014 AND VI 28

Results: 55

EXTEND II: An Open-Label Phase III Multicentre Study to Evaluate Efficacy and Safety of Ranibizumab in Chinese Patients with Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration.

Published in:

BioDrugs, 2014, v. 28, n. 6, p. 527, doi. 10.1007/s40259-014-0106-1

By:

Zhao, Jialiang;
Li, Xiaoxin;
Tang, Shibo;
Xu, Gezhi;
Xu, Xun;
Zhang, Feng;
Zhang, Meixia;
Shamsazar, Jila;
Pilz, Stefan;
Nieweg, Annette

Publication type:

Article

Role of Embedded Pure Xenogenous Bovine Platelet Gel on Experimental Tendon Healing, Modelling and Remodelling.

Published in:

BioDrugs, 2014, v. 28, n. 6, p. 537, doi. 10.1007/s40259-014-0107-0

By:

Oryan, Ahmad;
Moshiri, Ali;
Meimandi-Parizi, Abdolhamid

Publication type:

Article

Demonstration of Biosimilarity, Extrapolation of Indications and Other Challenges Related to Biosimilars in Europe.

Published in:

BioDrugs, 2014, v. 28, n. 6, p. 479, doi. 10.1007/s40259-014-0109-y

By:

Tsiftsoglou, Asterios;
Trouvin, Jean;
Calvo, Gonzalo;
Ruiz, Sol

Publication type:

Article

Harnessing the PD-1 Pathway in Renal Cell Carcinoma: Current Evidence and Future Directions.

Published in:

BioDrugs, 2014, v. 28, n. 6, p. 513, doi. 10.1007/s40259-014-0111-4

By:

Tripathi, Abhishek;
Drake, Charles;
Harshman, Lauren

Publication type:

Article

Acknowledgement to Referees.

Published in:: BioDrugs, 2014, v. 28, n. 6, p. 477, doi. 10.1007/s40259-014-0112-3
Publication type:: Article

Similar Names for Similar Biologics.

Published in:

BioDrugs, 2014, v. 28, n. 5, p. 439, doi. 10.1007/s40259-014-0099-9

By:

Casadevall, Nicole;
Felix, Thomas;
Strober, Bruce;
Warnock, David

Publication type:

Article

Optimisation of Omalizumab Dosage in Patients with Severe Persistent Allergic Asthma Using recoveryELISA.

Published in:

BioDrugs, 2014, v. 28, n. 5, p. 445, doi. 10.1007/s40259-014-0101-6

By:

Steiß, Jens-Oliver;
Becher, G.

Publication type:

Article

The Role of Interleukin-17A in Psoriatic Disease.

Published in:

BioDrugs, 2014, v. 28, n. 6, p. 487, doi. 10.1007/s40259-014-0098-x

By:

Adami, Silvano;
Cavani, Andrea;
Rossi, Francesco;
Girolomoni, Giampiero

Publication type:

Article

Making Choices: Health Consumers, Regulation and the Global Stem Cell Therapy Market.

Published in:

BioDrugs, 2014, v. 28, n. 5, p. 461, doi. 10.1007/s40259-014-0105-2

By:

Salter, Brian;
Zhou, Yinhua;
Datta, Saheli

Publication type:

Article

Elosulfase Alfa: A Review of Its Use in Patients with Mucopolysaccharidosis Type IVA (Morquio A Syndrome).

Published in:

BioDrugs, 2014, v. 28, n. 5, p. 465, doi. 10.1007/s40259-014-0108-z

By:

Lyseng-Williamson, Katherine

Publication type:

Article

Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Rationale and Issues for Further Clinical Development.

Published in:

BioDrugs, 2014, v. 28, n. 5, p. 421, doi. 10.1007/s40259-014-0097-y

By:

Sim, Geok;
Chacon, Jessica;
Haymaker, Cara;
Ritthipichai, Krit;
Singh, Manish;
Hwu, Patrick;
Radvanyi, Laszlo

Publication type:

Article

A Comprehensive Safety Evaluation of Trabectedin and Drug-Drug Interactions of Trabectedin-Based Combinations.

Published in:

BioDrugs, 2014, v. 28, n. 6, p. 499, doi. 10.1007/s40259-014-0100-7

By:

Leporini, Christian;
Patanè, Marinella;
Saullo, Francesca;
Rende, Pierandrea;
Gallelli, Luca;
Paola, Eugenio;
Toscano, Rosa;
Lucia, Maria;
Rossi, Marco;
Sarro, Giovambattista;
Russo, Emilio

Publication type:

Article

Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280014 and Trastuzumab (Herceptin).

Published in:

BioDrugs, 2014, v. 28, n. 5, p. 451, doi. 10.1007/s40259-014-0103-4

By:

Hurst, Susan;
Ryan, Anne;
Ng, Chee-Keng;
McNally, James;
Lorello, Leslie;
Finch, Gregory;
Leach, Michael;
Ploch, Stephen;
Fohey, Josh;
Smolarek, Teresa

Publication type:

Article

Human Immunoglobulin 10 % with Recombinant Human Hyaluronidase: Replacement Therapy in Patients with Primary Immunodeficiency Disorders.

Published in:

BioDrugs, 2014, v. 28, n. 4, p. 411, doi. 10.1007/s40259-014-0104-3

By:

Sanford, Mark

Publication type:

Article

siRNA Technology in Kidney Transplantation: Current Status and Future Potential.

Published in:

BioDrugs, 2014, v. 28, n. 4, p. 345, doi. 10.1007/s40259-014-0087-0

By:

Glebova, Kristina;
Reznik, Oleg;
Reznik, Alexander;
Mehta, Rohini;
Galkin, Alexander;
Baranova, Ancha;
Skoblov, Mikhail

Publication type:

Article

Drift, Evolution, and Divergence in Biologics and Biosimilars Manufacturing.

Published in:

BioDrugs, 2014, v. 28, n. 4, p. 363, doi. 10.1007/s40259-014-0088-z

By:

Ramanan, Sundar;
Grampp, Gustavo

Publication type:

Article

Purification, Characterization and Plasma Half-Life of PEGylated Soluble Recombinant Non-HA-Binding CD44.

Published in:

BioDrugs, 2014, v. 28, n. 4, p. 393, doi. 10.1007/s40259-014-0089-y

By:

Pink, Anne;
Kallastu, Aili;
Turkina, Marina;
Skolnaja, Marianna;
Kogerman, Priit;
Päll, Taavi;
Valkna, Andres

Publication type:

Article

Targeting the PI3K/Akt/mTOR Pathway in Malignancy: Rationale and Clinical Outlook.

Published in:

BioDrugs, 2014, v. 28, n. 4, p. 373, doi. 10.1007/s40259-014-0090-5

By:

Cho, Daniel

Publication type:

Article

Multi-Specific Antibodies for Cancer Immunotherapy.

Published in:

BioDrugs, 2014, v. 28, n. 4, p. 331, doi. 10.1007/s40259-014-0091-4

By:

Jachimowicz, Ron;
Borchmann, Sven;
Rothe, Achim

Publication type:

Article

Unexplained Abuses of Human IgG Subclass Denomination in Antibody Patents.

Published in:

BioDrugs, 2014, v. 28, n. 4, p. 327, doi. 10.1007/s40259-014-0095-0

By:

Pottier, Jérémy;
Watier, Hervé

Publication type:

Article

Practical Considerations for the Pharmacokinetic and Immunogenic Assessment of Antibody-Drug Conjugates.

Published in:

BioDrugs, 2014, v. 28, n. 4, p. 383, doi. 10.1007/s40259-014-0096-z

By:

Sauerborn, Melody;
Dongen, William

Publication type:

Article

Ranibizumab: A Review of its Use in Myopic Choroidal Neovascularization.

Published in:

BioDrugs, 2014, v. 28, n. 4, p. 403, doi. 10.1007/s40259-014-0102-5

By:

Deeks, Emma

Publication type:

Article

Erratum to: Second-Generation Tyrosine Kinase Inhibitors in First-Line Treatment of Chronic Myeloid Leukaemia (CML).

Published in:

BioDrugs, 2014, v. 28, n. 3, p. 325, doi. 10.1007/s40259-014-0093-2

By:

Abruzzese, Elisabetta;
Breccia, Massimo;
Latagliata, Roberto

Publication type:

Article

The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy.

Published in:

BioDrugs, 2014, v. 28, n. 3, p. 285, doi. 10.1007/s40259-014-0084-3

By:

Spandonaro, Federico;
Ayala, Fabio;
Berardesca, Enzo;
Chimenti, Sergio;
Girolomoni, Giampiero;
Martini, Patrizia;
Peserico, Andrea;
Polistena, Barbara;
Puglisi Guerra, Antonio;
Vena, Gino;
Altomare, Gianfranco;
Calzavara Pinton, Piergiacomo

Publication type:

Article

A Review of CT-P13: An Infliximab Biosimilar.

Published in:

BioDrugs, 2014, v. 28, n. 3, p. 313, doi. 10.1007/s40259-014-0094-1

By:

McKeage, Kate

Publication type:

Article

Bacteriophage Polysaccharide Depolymerases and Biomedical Applications.

Published in:

BioDrugs, 2014, v. 28, n. 3, p. 265, doi. 10.1007/s40259-013-0081-y

By:

Yan, Jianlong;
Mao, Jiaoxiao;
Xie, Jianping

Publication type:

Article

Safety and Pharmacokinetics of Escalating Doses of Human Recombinant Nerve Growth Factor Eye Drops in a Double-Masked, Randomized Clinical Trial.

Published in:

BioDrugs, 2014, v. 28, n. 3, p. 275, doi. 10.1007/s40259-013-0079-5

By:

Ferrari, Mauro;
Mantelli, Flavio;
Sacchetti, Marta;
Antonangeli, Maria;
Cattani, Franca;
D'Anniballe, Gaetano;
Sinigaglia, Francesco;
Ruffini, Pier;
Lambiase, Alessandro

Publication type:

Article

Management of Relapsed or Refractory Hodgkin Lymphoma with Second-Generation Antibody-Drug Conjugates: Focus on Brentuximab Vedotin.

Published in:

BioDrugs, 2014, v. 28, n. 3, p. 245, doi. 10.1007/s40259-013-0077-7

By:

Mei, Matthew;
Thomas, Sandra;
Chen, Robert

Publication type:

Article

Attenuation of Carbon Tetrachloride-Induced Hepatic Injury with Curcumin-Loaded Solid Lipid Nanoparticles.

Published in:

BioDrugs, 2014, v. 28, n. 3, p. 297, doi. 10.1007/s40259-014-0086-1

By:

Singh, Neha;
Khullar, Neeraj;
Kakkar, Vandita;
Kaur, Indu

Publication type:

Article

Calcitonin Gene-Related Peptide Targeted Immunotherapy for Migraine: Progress and Challenges in Treating Headache.

Published in:

BioDrugs, 2014, v. 28, n. 3, p. 237, doi. 10.1007/s40259-014-0083-4

By:

Peroutka, Stephen

Publication type:

Article

Erratum to: Bacteriophage Polysaccharide Depolymerases and Biomedical Applications.

Published in:

BioDrugs, 2014, v. 28, n. 3, p. 323, doi. 10.1007/s40259-014-0092-3

By:

Yan, Jianlong;
Mao, Jinxiao;
Xie, Jianping

Publication type:

Article

Management of Metastatic Breast Cancer with Second-Generation Antibody-Drug Conjugates: Focus on Glembatumumab Vedotin (CDX-011, CR011-vcMMAE).

Published in:

BioDrugs, 2014, v. 28, n. 3, p. 253, doi. 10.1007/s40259-014-0085-2

By:

Vaklavas, Christos;
Forero, Andres

Publication type:

Article

Tumour Necrosis Factor α Antagonists in the Treatment of Rheumatoid Arthritis: An Immunological Perspective.

Published in:

BioDrugs, 2014, v. 28, p. 5, doi. 10.1007/s40259-013-0063-0

By:

Meroni, Pier-Luigi;
Valesini, Guido

Publication type:

Article

How FABulous is PEGgy? Certoliziumab Pegol from the Bench to the Patients.

Published in:

BioDrugs, 2014, v. 28, p. 3, doi. 10.1007/s40259-013-0067-9

By:

Aletaha, Daniel

Publication type:

Article

Pegylation of Biological Molecules and Potential Benefits: Pharmacological Properties of Certolizumab Pegol.

Published in:

BioDrugs, 2014, v. 28, p. 15, doi. 10.1007/s40259-013-0064-z

By:

Pasut, Gianfranco

Publication type:

Article

CD30 as a Therapeutic Target for Lymphoma.

Published in:

BioDrugs, 2014, v. 28, n. 2, p. 181, doi. 10.1007/s40259-013-0068-8

By:

Schirrmann, Thomas;
Steinwand, Miriam;
Wezler, Xenia;
Haaf, Andre;
Tur, Mehmet;
Barth, Stefan

Publication type:

Article

Antibody-Cytokine Fusion Proteins for Cancer Immunotherapy: An Update on Recent Developments.

Published in:

BioDrugs, 2014, v. 28, n. 2, p. 123, doi. 10.1007/s40259-013-0069-7

By:

Müller, Dafne

Publication type:

Article

Efficacy and Safety of Certolizumab Pegol in Rheumatoid Arthritis: Meeting Rheumatologists' Requirements in Routine Clinical Practice.

Published in:

BioDrugs, 2014, v. 28, p. 25, doi. 10.1007/s40259-013-0065-y

By:

Punzi, Leonardo;
Lapadula, Giovanni;
Mathieu, Alessandro

Publication type:

Article

Efficacy and Safety of Biologic Therapies for Systemic Lupus Erythematosus Treatment: Systematic Review and Meta-Analysis.

Published in:

BioDrugs, 2014, v. 28, n. 2, p. 211, doi. 10.1007/s40259-013-0074-x

By:

Borba, Helena;
Wiens, Astrid;
Souza, Thais;
Correr, Cassyano;
Pontarolo, Roberto

Publication type:

Article

Drug Desensitization in the Management of Hypersensitivity Reactions to Monoclonal Antibodies and Chemotherapy.

Published in:

BioDrugs, 2014, v. 28, n. 2, p. 133, doi. 10.1007/s40259-013-0066-x

By:

Mezzano, Veronica;
Giavina-Bianchi, Pedro;
Picard, Matthieu;
Caiado, Joana;
Castells, Mariana

Publication type:

Article

Interferon-Free Regimens for Hepatitis C: Combine and Conquer.

Published in:

BioDrugs, 2014, v. 28, n. 2, p. 161, doi. 10.1007/s40259-013-0072-z

By:

Martel-Laferrière, Valérie;
Bichoupan, Kian;
Dieterich, Douglas

Publication type:

Article

Optimisation of TNF-Inhibitor Therapy for Rheumatoid Arthritis: Focus on Certolizumab Pegol.

Published in:: BioDrugs, 2014, v. 28, p. 1, doi. 10.1007/s40259-013-0080-z
Publication type:: Article

Recent advances on host plants and expression cassettes' structure and function in plant molecular pharming.

Published in:

BioDrugs, 2014, v. 28, n. 2, p. 145, doi. 10.1007/s40259-013-0062-1

By:

Makhzoum, Abdullah;
Benyammi, Roukia;
Moustafa, Khaled;
Trémouillaux-Guiller, Jocelyne

Publication type:

Article

Genetically Engineered Humanized Mouse Models for Preclinical Antibody Studies.

Published in:

BioDrugs, 2014, v. 28, n. 2, p. 171, doi. 10.1007/s40259-013-0071-0

By:

Proetzel, Gabriele;
Wiles, Michael;
Roopenian, Derry

Publication type:

Article

Systemic Therapy for Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in Nationally Representative US Claims Database.

Published in:

BioDrugs, 2014, v. 28, n. 2, p. 229, doi. 10.1007/s40259-013-0073-y

By:

Seal, Brian;
Sullivan, Sean;
Ramsey, Scott;
Shermock, Kenneth;
Ren, Jinma;
Kreilick, Charlie;
Boklage, Susan;
Valluri, Satish;
Sarma, Syam;
Asche, Carl

Publication type:

Article

A Novel Double-Enhanced Suicide Gene Therapy in a Colon Cancer Cell Line Mediated by Gef and Apoptin.

Published in:

BioDrugs, 2014, v. 28, n. 1, p. 63, doi. 10.1007/s40259-013-0055-0

By:

Boulaiz, Houria;
Aránega, Antonia;
Blanca, Cáceres;
Pablo, Alvarez;
Fernando, Rodríguez-Serrano;
Esmeralda, Carrillo;
Consolación, Melguizo;
Jose, Prados

Publication type:

Article

Pharmaceutical Costs of Desensitization Therapy in Patients Awaiting Lung Transplantation in France.

Published in:

BioDrugs, 2014, v. 28, n. 1, p. 55, doi. 10.1007/s40259-013-0054-1

By:

Liu, Annaë;
Bernard, Mélisande

Publication type:

Article

Evidence for the Use of Biological Therapies in Ulcers of the Foot in Diabetes.

Published in:

BioDrugs, 2014, v. 28, n. 1, p. 1, doi. 10.1007/s40259-013-0052-3

By:

Jeffcoate, William;
Game, Frances

Publication type:

Article

Targeting Survivin in Cancer: Novel Drug Development Approaches.

Published in:

BioDrugs, 2014, v. 28, n. 1, p. 27, doi. 10.1007/s40259-013-0058-x

By:

Groner, Bernd;
Weiss, Astrid

Publication type:

Article

Treg Vaccination in Autoimmune Type 1 Diabetes.

Published in:

BioDrugs, 2014, v. 28, n. 1, p. 7, doi. 10.1007/s40259-013-0060-3

By:

Serr, Isabelle;
Weigmann, Benno;
Franke, Randi;
Daniel, Carolin

Publication type:

Article